These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30230019)

  • 21. Sex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses From the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study.
    Espeland MA; Hayden KM; Lockhart SN; Yassine HN; Hoscheidt S; Yasar S; Luchsinger JA; Neiberg RH; Diaz Brinton R; Carmichael O
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):771-778. PubMed ID: 30997482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging.
    Bos D; Vernooij MW; Elias-Smale SE; Verhaaren BF; Vrooman HA; Hofman A; Niessen WJ; Witteman JC; van der Lugt A; Ikram MA
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S104-11. PubMed ID: 22537801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter hyperintensity shape is associated with cognitive functioning - the SMART-MR study.
    Zwartbol MHT; Ghaznawi R; Jaarsma-Coes M; Kuijf H; Hendrikse J; de Bresser J; Geerlings MI;
    Neurobiol Aging; 2022 Dec; 120():81-87. PubMed ID: 36152446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume.
    Wessels AM; Rombouts SA; Remijnse PL; Boom Y; Scheltens P; Barkhof F; Heine RJ; Snoek FJ
    Diabetologia; 2007 Aug; 50(8):1763-9. PubMed ID: 17546438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample.
    Kumar R; Anstey KJ; Cherbuin N; Wen W; Sachdev PS
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):989-98. PubMed ID: 19038898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
    Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
    Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Hugenschmidt CE; Lovato JF; Ambrosius WT; Bryan RN; Gerstein HC; Horowitz KR; Launer LJ; Lazar RM; Murray AM; Chew EY; Danis RP; Williamson JD; Miller ME; Ding J
    Diabetes Care; 2014 Dec; 37(12):3244-52. PubMed ID: 25193529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.
    Jongen C; van der Grond J; Kappelle LJ; Biessels GJ; Viergever MA; Pluim JP;
    Diabetologia; 2007 Jul; 50(7):1509-16. PubMed ID: 17492428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?
    Biessels GJ; Reijmer YD
    Diabetes; 2014 Jul; 63(7):2244-52. PubMed ID: 24931032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycated haemoglobin (HbA
    Dyer AH; Briggs R; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
    Diabet Med; 2021 Nov; 38(11):e14668. PubMed ID: 34343367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning.
    van Bussel FCG; Backes WH; Hofman PAM; Puts NAJ; Edden RAE; van Boxtel MPJ; Schram MT; Stehouwer CDA; Wildberger JE; Jansen JFA
    Medicine (Baltimore); 2016 Sep; 95(36):e4803. PubMed ID: 27603392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.
    van den Berg E; Reijmer YD; de Bresser J; Kessels RP; Kappelle LJ; Biessels GJ;
    Diabetologia; 2010 Jan; 53(1):58-65. PubMed ID: 19882137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities.
    Alfaro FJ; Lioutas VA; Pimentel DA; Chung CC; Bedoya F; Yoo WK; Novak V
    J Neurol; 2016 Dec; 263(12):2505-2514. PubMed ID: 27730376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control.
    West RK; Ravona-Springer R; Schmeidler J; Leroith D; Koifman K; Guerrero-Berroa E; Preiss R; Hoffman H; Silverman JM; Heymann A; Schnaider-Beeri M
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1055-9. PubMed ID: 24534521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression.
    Köhler S; Thomas AJ; Lloyd A; Barber R; Almeida OP; O'Brien JT
    Br J Psychiatry; 2010 Feb; 196(2):143-9. PubMed ID: 20118461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes mellitus patients with proliferative retinopathy.
    van Duinkerken E; Steenwijk MD; Klein M; Barkhof F; Mograbi DC; Diamant M; Snoek FJ; Ijzerman RG
    J Diabetes; 2018 Nov; 10(11):835-846. PubMed ID: 29665283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
    van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
    Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
    Manschot SM; Biessels GJ; de Valk H; Algra A; Rutten GE; van der Grond J; Kappelle LJ;
    Diabetologia; 2007 Nov; 50(11):2388-97. PubMed ID: 17764005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.
    Raffield LM; Brenes GA; Cox AJ; Freedman BI; Hugenschmidt CE; Hsu FC; Xu J; Wagner BC; Williamson JD; Maldjian JA; Bowden DW
    J Diabetes Complications; 2016; 30(1):143-9. PubMed ID: 26476474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults.
    Feng L; Isaac V; Sim S; Ng TP; Krishnan KR; Chee MW
    Am J Geriatr Psychiatry; 2013 Feb; 21(2):164-72. PubMed ID: 23343490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.